BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34094547)

  • 1. Cytological and molecular diagnosis of Hürthle cell thyroid tumors: Analysis of three cases.
    Titov SE; Poloz TL; Veryaskina YA; Anishchenko VV
    Mol Clin Oncol; 2021 Jul; 15(1):149. PubMed ID: 34094547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined quantitation of HMGA2 mRNA, microRNAs, and mitochondrial-DNA content enables the identification and typing of thyroid tumors in fine-needle aspiration smears.
    Titov SE; Ivanov MK; Demenkov PS; Katanyan GA; Kozorezova ES; Malek AV; Veryaskina YA; Zhimulev IF
    BMC Cancer; 2019 Oct; 19(1):1010. PubMed ID: 31660895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Typing of Thyroid and Parathyroid Tumors with a Combined Molecular Classifier.
    Titov SE; Kozorezova ES; Demenkov PS; Veryaskina YA; Kuznetsova IV; Vorobyev SL; Chernikov RA; Sleptsov IV; Timofeeva NI; Ivanov MK
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33440616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can abundant colloid exclude oncocytic (Hürthle cell) carcinoma in thyroid fine needle aspiration? Cytohistological correlation of 127 oncocytic (Hürthle cell) lesions.
    Yang GC; Schreiner AM; Sun W
    Cytopathology; 2013 Jun; 24(3):185-93. PubMed ID: 22672530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of accordance between cytological and histopathological findings in selected thyroid tumors].
    Gołkowski F; Jabrocka A; Huszno B; Trofimiuk M; Buziak-Bereza M; Kulig J; Cichoń S
    Przegl Lek; 2004; 61(1):10-2. PubMed ID: 15230098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appearance of Hürthle cell carcinoma soon after surgical extirpation of Hürthle cell adenoma and follicular adenoma of the thyroid gland.
    Ristevska N; Stojanoski S; Gjorceva DP
    Radiol Oncol; 2015 Mar; 49(1):26-31. PubMed ID: 25810698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of nonpalpable thyroid nodules)].
    Miseikyte-Kaubriene E; Ulys A; Trakymas M
    Medicina (Kaunas); 2008; 44(3):189-94. PubMed ID: 18413985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
    Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of specific patterns on the sensitivity for follicular and Hurthle cell carcinoma in thyroid fine-needle aspiration.
    Renshaw AA; Gould EW
    Cancer Cytopathol; 2016 Oct; 124(10):729-736. PubMed ID: 27322887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Presence of Hürthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates.
    Ren Y; Kyriazidis N; Faquin WC; Soylu S; Kamani D; Saade R; Torchia N; Lubitz C; Davies L; Stathatos N; Stephen AE; Randolph GW
    Thyroid; 2020 Mar; 30(3):425-431. PubMed ID: 32013786
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
    Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
    Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncocytic variant of papillary thyroid carcinoma associated with Hashimoto's thyroiditis: a case report and review of the literature.
    Lee J; Hasteh F
    Diagn Cytopathol; 2009 Aug; 37(8):600-6. PubMed ID: 19526577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Characterization of an Endometrial Endometrioid Adenocarcinoma Metastatic to a Thyroid Hürthle Cell Adenoma Showing Cancerization of Follicles.
    Afrogheh AH; Meserve E; Sadow PM; Stephen AE; Nosé V; Berlin S; Faquin WC
    Endocr Pathol; 2016 Sep; 27(3):213-9. PubMed ID: 26687112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hurthle cells in fine needle aspiration cytology of the thyroid: a potential diagnostic dilemma?
    Wong YP; Md Isa N; Md Zin RR; Noor Akmal S
    Malays J Pathol; 2015 Apr; 37(1):49-52. PubMed ID: 25890614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification in follicular neoplasm: a cytological assessment using the modified Bethesda classification.
    Ustun B; Chhieng D; Van Dyke A; Carling T; Holt E; Udelsman R; Adeniran AJ
    Cancer Cytopathol; 2014 Jul; 122(7):536-45. PubMed ID: 24753500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytological evaluation by fine needle aspiration biopsy of incidental focal increased fluorodeoxyglucose uptake in thyroid on positron emission tomography scan.
    Li Y; Cui M; Azar N; Nakamoto D; Michael CW
    Diagn Cytopathol; 2017 Jun; 45(6):501-506. PubMed ID: 28261999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine needle aspiration of poorly differentiated oxyphilic (Hürthle cell) thyroid carcinoma: a case report.
    Ghofrani M; Sosa JA; Ocal IT; Angeletti C
    Acta Cytol; 2006; 50(5):560-2. PubMed ID: 17017447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hürthle cell lesions on thyroid fine needle aspiration cytology: Molecular and histologic correlation.
    Schatz-Siemers N; Brandler TC; Oweity T; Sun W; Hernandez A; Levine P
    Diagn Cytopathol; 2019 Oct; 47(10):977-985. PubMed ID: 31293091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection and validation of miRNAs as normalizers for profiling expression of microRNAs isolated from thyroid fine needle aspiration smears.
    Titov SE; Demenkov PS; Ivanov MK; Malakhina ES; Poloz TL; Tsivlikova EV; Ganzha MS; Shevchenko SP; Gulyaeva LF; Kolesnikov NN
    Oncol Rep; 2016 Nov; 36(5):2501-2510. PubMed ID: 27666315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.